Premedication with pioglitazone prevents doxorubicin-induced left ventricular dysfunction in mice

Abstract Background Doxorubicin (DOX) is widely used as an effective chemotherapeutic agent for cancers; however, DOX induces cardiac toxicity, called DOX-induced cardiomyopathy. Although DOX-induced cardiomyopathy is known to be associated with a high cumulative dose of DOX, the mechanisms of its l...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Takaaki Furihata, Satoshi Maekawa, Shingo Takada, Naoya Kakutani, Hideo Nambu, Ryosuke Shirakawa, Takashi Yokota, Shintaro Kinugawa
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2021-05-01
Serija:	BMC Pharmacology and Toxicology
Teme:	Anticancer agent LV dysfunction Cardiac toxicity Thiazolidinediones
Online dostop:	https://doi.org/10.1186/s40360-021-00495-w
Oznake:	Označite Brez oznak, prvi označite!